CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 3
- ScaleMarket cap is $2.59B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.99: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.59BUSDvs all stocks (USD)
Revenue (TTM)
2.58BUSDvs all stocks (USD)
Profit Margin
-1.62%Beta
2.75xvs all stocks
52-Week Change
47.64%vs all stocks
Market Capitalization
2.59BUSDvs all stocks (USD)
Enterprise Value
1.97BUSDvs all stocks (USD)
Forward P/E
72.02xPrice to Sales (TTM)
1.00xPrice to Book (MRQ)
5.08xEnterprise to Revenue
0.7640xEnterprise to EBITDA
-106.95xGross Margin
10.03%Profit Margin
-1.62%Operating Margin
-8.43%Return on Assets (TTM)
-1.32%Return on Equity (TTM)
-12.72%Revenue (TTM)
2.58BUSDvs all stocks (USD)
Revenue per Share (TTM)
19.66USDUpdated Jul 18, 2026Quarterly Revenue Growth
7.70%Gross Profit (TTM)
302.60MUSDvs all stocks (USD)
EBITDA (TTM)
-18.45MUSDvs all stocks (USD)
Net Income (TTM)
-41.80MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
7.71%Operating Cash Flow (TTM)
-236.03MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-133.67MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
119.25MUSDFY2025 · Sep 30, 2025Revenue
2.26BUSDFY2025 · Sep 30, 2025Cost of Goods Sold
1.97BUSDFY2025 · Sep 30, 2025Gross Profit
295.79MUSDFY2025 · Sep 30, 2025Operating Income
-46.34MUSDvs all stocks (USD)
Pre-tax Income
-45.07MUSDFY2025 · Sep 30, 2025Income Tax Expense
22.92MUSDFY2025 · Sep 30, 2025Net Income
-67.99MUSDFY2025 · Sep 30, 2025EBIT
-46.34MUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
-16.99MUSDFY2025 · Sep 30, 2025Research & Development
86.22MUSDFY2025 · Sep 30, 2025Selling, General & Administrative
242.56MUSDFY2025 · Sep 30, 2025EPS (Basic)
-0.3700USDFY2025 · Sep 30, 2025EPS (Diluted)
-0.3700USDFY2025 · Sep 30, 2025Basic Shares Outstanding
130.31MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
130.31MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
-67.99MUSDFY2025 · Sep 30, 2025Minority Interests (P&L)
19.68MUSDFY2025 · Sep 30, 2025Operating Cash Flow
-80.13MUSDFY2025 · Sep 30, 2025Free Cash Flow
-95.02MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
714.63MUSDFY2025 · Sep 30, 2025Income Tax Paid
19.04MUSDFY2025 · Sep 30, 2025Interest Paid
9.30MUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
-67.99MUSDFY2025 · Sep 30, 2025Depreciation & Amortization
29.34MUSDFY2025 · Sep 30, 2025Deferred Taxes (CF)
6.35MUSDFY2025 · Sep 30, 2025Stock-based Compensation
19.54MUSDFY2025 · Sep 30, 2025Other Non-cash Items
4.22MUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
37.02MUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
-119.23MUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
10.61MUSDFY2025 · Sep 30, 2025Capital Expenditures
-14.88MUSDFY2025 · Sep 30, 2025Net Acquisitions
0.00USDFY2025 · Sep 30, 2025Sale of Investments
0.00USDFY2025 · Sep 30, 2025Net Investing Cash Flow
-14.88MUSDFY2025 · Sep 30, 2025Long-term Debt Issuance
400.00MUSDFY2025 · Sep 30, 2025Long-term Debt Payments
-31.37MUSDFY2025 · Sep 30, 2025Common Stock Repurchase
-753.00KUSDFY2025 · Sep 30, 2025Other Financing Charges
-13.17MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
354.71MUSDFY2025 · Sep 30, 2025Shares Outstanding
132.78MSharesUpdated Jul 18, 2026Float Shares
100.32MSharesUpdated Jul 18, 2026Shares Short
25.75MSharesUpdated Jul 18, 2026Short Ratio
1.90daysvs all stocks
Short % of Shares Outstanding
39.04%vs all stocks
% Held by Insiders
14.45%vs all stocks
% Held by Institutions
85.46%vs all stocks
Total Cash (MRQ)
387.30MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.92USDUpdated Jul 18, 2026Total Debt (MRQ)
401.97MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.8773xCurrent Ratio (MRQ)
1.44xBook Value per Share (MRQ)
2.77USDUpdated Jul 18, 2026Total Assets
2.36BUSDvs all stocks (USD)
Total Current Assets
2.06BUSDFY2025 · Sep 30, 2025Total Liabilities
1.81BUSDFY2025 · Sep 30, 2025Total Non-current Assets
292.74MUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
437.78MUSDFY2025 · Sep 30, 2025Total Current Liabilities
1.37BUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
690.77MUSDFY2025 · Sep 30, 2025Accounts Receivable
299.44MUSDFY2025 · Sep 30, 2025Inventory
455.01MUSDFY2025 · Sep 30, 2025Accounts Payable
321.00MUSDFY2025 · Sep 30, 2025Deferred Revenue
720.37MUSDFY2025 · Sep 30, 2025Other Current Liabilities
20.59MUSDFY2025 · Sep 30, 2025Long-term Debt
390.80MUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
37.45MUSDFY2025 · Sep 30, 2025Common Stock (Book)
1.00KUSDFY2025 · Sep 30, 2025Retained Earnings
-199.76MUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
548.85MUSDvs all stocks (USD)
Treasury Stock
10.21MUSDFY2025 · Sep 30, 202552-Week Low
6.60USDUpdated Jul 18, 202652-Week High
33.51USDUpdated Jul 18, 202652-Week Change
47.64%vs all stocks
Beta
2.75xvs all stocks
50-Day MA
20.55USDUpdated Jul 18, 2026200-Day MA
18.93USDUpdated Jul 18, 2026Avg 10-Day Volume
8.53MSharesUpdated Jul 18, 2026Avg 30-Day Volume
10.15MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.3100USDUpdated Jul 18, 2026Other Income / Expense
5.38MUSDFY2025 · Sep 30, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.99: grey zoneSignificant
Altman Z-Score: 1.99
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Market cap is $2.59B, above the global median of $1.15BNotable
Market cap (USD): 2,593,251,337Global Median: 1,146,734,693.424
Revenue is $2.58B, above the global median of $520.53MNotable
Revenue (USD): 2,584,549,120Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Bloomage Biotechnology Corp.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Quaker Chemical Corporation
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Xianhe Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hangzhou Hirisun Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Kunshan Dongwei Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Kaishan Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Chung-Hsin Electric & Machinery Manufacturing Corp.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sasa Polyester Sanayi A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Jack Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Ingevity Corporation
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Neuromeka Co., Ltd.
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated